Is a Third Dose of MMRV Vaccine Beneficial for the Adult Population in Alberta? — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Is a Third Dose of MMRV Vaccine Beneficial for the Adult Population in Alberta? — Stella

Recruiting

Back to Vaccination Failure trials

Trial locations(1 site)

Canada

University of Alberta, Edmonton, Alberta

Key details

Sponsor

University of Alberta

Collaborators

Merck Canada Inc.

Enrollment target

~200 participants

Started

November 2024

Primary completion

September 2027

Age range

18 Years and older

Sex

Female only

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov